![]() |
From the outset, health technology companies need to integrate health economics and Health outcomes research in their product development strategy in order to ensure a focus on the market and to maximise reimbursement, funding, uptake and market access at launch and beyond. In order to help companies achieve this, phmr consulting offers a full range of services including:
phmr consulting can help inform the pricing decision by generating Value Based Pricing evaluations that allow companies to examine the cost-effectiveness of different price points and use in different patient sub-groups. We conduct "what if" analyses to help clients understand the implications of pricing for market access, product uptake and the cost-effectiveness of products in "real world" use. In addition these analyses can be used to advise on the economic consequences of positioning decisions and help clients understand how such decisions may affect potential market size, pricing, reimbursement and market access. Communication and Publications It is vitally important for health technology companies to communicate key economic information effectively throughout the company if they are to realise a return on their investment in health economics through improved access in each market. One particularly useful vehicle for effective communication is a Health Outcomes Assessment Dossier, designed to collate and summarise all the relevant health economics and outcomes data that has been developed in support of the new product. Topics included are:
|